Products of Vitamin D3 or 7-Dehydrocholesterol Metabolism by Cytochrome P450scc Show Anti-Leukemia Effects, Having Low or Absent Calcemic Activity
Andrzej T. Slominski, Zorica Janjetovic, Brian E. Fuller et al. · 2010
Read Products of Vitamin D3 or 7-Dehydrocholesterol Metabolism by Cytochrome P450scc Show Anti-Leukemia Effects, Having Low or Absent Calcemic Activity by Andrzej T. Slominski, Zorica Janjetovic, Brian E. Fuller et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009907.txt.
Description
Vitamin D compounds can slow leukemia cells, but many also raise blood calcium dangerously. Andrzej Slominski and colleagues tested safer products made from vitamin D building blocks. Their study appeared in PLOS ONE in 2010. Calcemic activity means raising calcium levels in the blood.
The products came from vitamin D3 or from 7-dehydrocholesterol, processed by the enzyme cytochrome P450scc. They showed anti-leukemia effects in the tests. Crucially, they had low or absent calcemic activity, so they did not spike calcium. Safer vitamin D relatives could widen treatment options. Low calcium risk is the key gain here.
Catalog record
| CREATOR | Andrzej T. Slominski, Zorica Janjetovic, Brian E. Fuller et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009907